Skip to Main Content

Paper Details

Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity.
Am J Med
1
2022
Author NameAffiliation
Jerry H GurwitzChan Medical School, University of Massachusetts
Alan S GoKaiser Permanente Northern California, Kaiser Permanente Bernard J. Tyson School of Medicine, University of California, Stanford University
  • 1 - 2

Datasets

Release 1.2